US 11268096
Compounds for modulating Fc-epsilon-RI-beta expression and uses thereof
granted A61KA61K31/7088A61P
Quick answer
US patent 11268096 (Compounds for modulating Fc-epsilon-RI-beta expression and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7088, A61P, A61P29/00